| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/22/2001 | WO2001019369A1 Use of thienopyrimidines |
| 03/22/2001 | WO2001019368A1 Quinolinone derivative preparations and process for producing the same |
| 03/22/2001 | WO2001019367A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 03/22/2001 | WO2001019366A1 Topical treatment for prevention of ocular infections |
| 03/22/2001 | WO2001019365A1 Pharmaceutical and/or cosmetical compositions |
| 03/22/2001 | WO2001019364A1 A method for optimizing pupil size using alpha antagonist |
| 03/22/2001 | WO2001019363A1 Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 03/22/2001 | WO2001019362A2 Formulations for treating or preventing mucositis |
| 03/22/2001 | WO2001019361A2 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 03/22/2001 | WO2001019360A2 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 03/22/2001 | WO2001019359A2 Medicaments containing pantothenic acid for the treatment of inflammatory joint disease |
| 03/22/2001 | WO2001019358A2 Use dexrazoxane for treating psoriasis |
| 03/22/2001 | WO2001019356A2 High lipid diet |
| 03/22/2001 | WO2001019355A2 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/22/2001 | WO2001019354A2 Composition for ivf |
| 03/22/2001 | WO2001019353A2 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/22/2001 | WO2001019352A1 Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines |
| 03/22/2001 | WO2001019351A1 Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 03/22/2001 | WO2001019350A1 Controlled release formulation for administration of an anti-inflammatory naphthalene derivative |
| 03/22/2001 | WO2001019349A2 Extended release formulation of etodolac |
| 03/22/2001 | WO2001019348A1 Stabilization of enalapril maleate with maleic acid |
| 03/22/2001 | WO2001019347A1 Vascular coating composition |
| 03/22/2001 | WO2001019346A1 Delayed release nabumetone formulation |
| 03/22/2001 | WO2001019342A2 Pharmaceutical formulation of fluticasone propionate |
| 03/22/2001 | WO2001019341A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | WO2001019340A1 Dispersion formulations containing lipase inhibitors |
| 03/22/2001 | WO2001019339A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | WO2001019338A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 03/22/2001 | WO2001019337A2 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 03/22/2001 | WO2001019336A1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 03/22/2001 | WO2001019334A2 Pharmaceutical solutions of levosimendan |
| 03/22/2001 | WO2001019323A1 Tyrosinase activity inhibitors and cosmetics |
| 03/22/2001 | WO2001019322A2 Use of csaids in rhinovirus infection |
| 03/22/2001 | WO2001019321A2 Methods for treating neuropathic pain using hetreoarylmethanesulfonamides |
| 03/22/2001 | WO2001019320A2 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | WO2001019204A1 Breath freshening comestible product |
| 03/22/2001 | WO2001019191A1 Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 03/22/2001 | WO2001019161A2 ANTISENSE MODULATION OF TRANSFORMING GROWTH FACTOR-β EXPRESSION |
| 03/22/2001 | WO2001019158A2 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 03/22/2001 | WO2001008661A3 Opioid sustained-released formulation |
| 03/22/2001 | WO2001005435A3 Antisense therapy for hormone-regulated tumors |
| 03/22/2001 | WO2001000188A3 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and their use for preventing and/or treating anaemia |
| 03/22/2001 | WO2000078341A8 A method for the prophylaxis and/or treatment of medical disorders |
| 03/22/2001 | WO2000074629A3 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000069862A3 Hemisynthetic method and intermediates thereof |
| 03/22/2001 | WO2000069421A3 Transdermal therapeutic system (tts) containing tolterodine |
| 03/22/2001 | WO2000069255A8 Anti-inflammatory therapy for inflammatory mediated infection |
| 03/22/2001 | WO2000068229A3 (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents |
| 03/22/2001 | WO2000066096A3 Use of antiepileptics for treating respiratory disorders, in particular asthmatic disorders |
| 03/22/2001 | WO2000061134A8 Antimicrobial agents |
| 03/22/2001 | WO2000059899A8 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000040576A3 Thiopyran compounds as inhibitors of mmp |
| 03/22/2001 | WO2000035469A9 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER |
| 03/22/2001 | WO2000035435A9 Use of a mek inhibitor for preventing transplant rejection |
| 03/22/2001 | WO2000032177A3 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | WO1999067809A9 Compositions and methods for inhibiting bone resorption |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | WO1999051240A8 Acylbenzoxazines for enhancing synaptic response(s) |
| 03/22/2001 | DE19944604A1 Aminderivate Amine derivatives |
| 03/22/2001 | DE19944464A1 Verfahren zur Herstellung von Polyvinylpyrrolidon-lod in wässriger Lösung A process for preparing polyvinylpyrrolidone-iodine in aqueous solution |
| 03/22/2001 | DE19944404A1 Mittel zur Therapie von menschlichen Erkrankungen, insbesondere für die Therapie von Tumoren wie Kolonkarzinomen und Melanomen oder zur Geweberegeneration und Förderung des Haarwuchses Means for therapy of human disease, in particular for the treatment of tumors such as colon carcinoma and melanoma, or for tissue regeneration and promote hair growth |
| 03/22/2001 | DE19944332A1 Antikonvulsiv und anxiolytisch wirkende 4-Amino-1-aryl-1,5-dihydro-pyrrol-2-one und Verfahren zu deren Herstellung Anticonvulsant and anxiolytic 4-amino-1-aryl-1,5-dihydro-pyrrol-2-one and processes for their preparation |
| 03/22/2001 | DE19944137A1 O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin O / W emulsions with a content of one or more bioquinones and an elevated content of glycerol |
| 03/22/2001 | DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/22/2001 | CA2672722A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | CA2388383A1 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/22/2001 | CA2387123A1 Use of thienopyrimidines |
| 03/22/2001 | CA2386525A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2385722A1 Use of csaids in rhinovirus infection |
| 03/22/2001 | CA2385589A1 Inhibitors of factor xa |
| 03/22/2001 | CA2385065A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | CA2385063A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 03/22/2001 | CA2384991A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | CA2384987A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | CA2384986A1 Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines |
| 03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | CA2384898A1 Antiviral agents |
| 03/22/2001 | CA2384861A1 Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
| 03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384782A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384763A1 Tryptase inhibitors |
| 03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384726A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 03/22/2001 | CA2384685A1 Use dexrazoxane for treating psoriasis |
| 03/22/2001 | CA2384656A1 New active marine alkaloids |
| 03/22/2001 | CA2384646A1 Taxane prodrugs |
| 03/22/2001 | CA2384645A1 Amphiphilic prodrugs |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2384247A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | CA2384246A1 Glucosamine and egg reducing inflammation |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383988A1 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |